Dr Dennis Chan will discuss:

- Diagnostics based on wearable tech and AI can revolutionise detection of preclinical disease

- Active testing of cognition will be combined with passive sensing of motor and autonomic function, sleep, language

- Challenges for digital approaches include privacy preservation, data governance and futureproofing
  • 1624993327-566abc758917c3d0
    Dr Dennis Chan
    Principal Clinical Research Fellow, Institute of Cognitive Neuroscience, University College London
    Dennis Chan is a consultant neurologist and Principal Clinical Research Fellow at the UCL Institute of Cognitive Neuroscience. His research focuses on the use of entorhinal cortex-hippocampal tests to detect the onset of AD in transgenic mice and at-risk human cohorts, and on the development of novel diagnostic toolkits based on wearable tech. He is one of the group leaders for the national EDoN (Early Detection of Neurodegenerative Disease) initiative https://edon-initiative.org.

    Dr Chan is funded by Alzheimer’s Research UK, the UCL Sainsbury Wellcome Centre and the Wellcome Trust.